Shenzhen Eye Hospital — Shenzhen, Guangdong

Public research footprint of Shenzhen Eye Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

Neovascular Age-Related Macular Degeneration (nAMD) · Wet Age-related Macular Degeneration (wAMD) · Polypoidal Choroidal Vasculopathy (PCV) · Diabetic Macular Edema

Recently updated registry entries

NCT07740564 — Phase III Study of OT202 in Treating Moderate to Severe Dry Eye (Not Yet Recruiting)
NCT07640997 — Real-world Study of Aflibercept 8 mg in nAMD (Recruiting)
NCT06666855 — A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Shenzhen Eye Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.